New combo therapy for mesothelioma: radiation plus surgery under study
NCT ID NCT04028570
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new approach for people with malignant pleural mesothelioma, a rare lung cancer. It combines high-dose radiation (including a special boost to target bulky tumors) with surgery to remove the affected tissue. The main goal is to find the highest safe radiation dose that doesn't cause severe lung injury. Only 15 participants are enrolled, making this an early-stage feasibility study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy (background and boost radiation)
What this could lead to
If successful, this could point toward a safer way to combine high-dose radiation with surgery for mesothelioma, potentially improving disease control.
What could go wrong
This is a very small, early feasibility study with only 15 participants, so results may not apply broadly. There is a risk of serious lung injury from the radiation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MESOTHELIOMA; LUNG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Hospital, University Health Network
Toronto, Ontario, M5G 2M9, Canada